ADVISORY: The 5th European Biotechnology Symposium ``Realizing the Potential of Biotechnology''.News/Assignment Editors, Health, Medical & High-Tech Writers ADVISORY... for Sunday (Sept. 29) BIOWIRE2K --(BUSINESS WIRE) Last chance to register for this symposium and join this symposium which will be attended by senior managers of biopharmaceutical companies and pharmaceutical companies. The 5th European Biotechnology Symposium runs 29 September - October 1st at the Bayerischer Hof Hof (hōf), city (1994 pop. 52,720), Bavaria, E central Germany, on the Saale River, near the Czech border. The city's industries produce textiles, beer, and machinery. Hof was first mentioned in the early 13th cent. and in 1373 passed to the Hohenzollern burgraviate of Nuremburg. Hotel in Munich, during the world famous Octoberfest. This symposium presented by Genetic Engineering genetic engineering n.
News, will address issues facing emerging and established European
Companies developing and manufacturing biopharmaceuticals, and cover new
technological developments and provides an opportunity to gain a
pan-European view of the industry and its business environment with the
emphasis on "Realizing the Potential of Biotechnology".
Scientific alteration of the structure of genetic material in a living organism using recombinant DNA, employed for such purposes as creating bacteria that synthesize insulin.
What: The 5th European Biotechnology Symposium - "Realizing the
Potential of Biotechnology"
When: September 29 - October 1, 2002. Opening 6:00 PM Sunday
concluding 5:30 PM Tuesday
Where: Bayerischer Hof Hotel, Munich, Germany - Phone: + 49 (0) 90
2120-0
Who:
Dr. Tony Bradshaw, Programme Chair, Head of Healthcare, Harvey
Nash
John Sterling, Managing Editor Genetic Engineering News
James Chistie, Protherics PLC - Global Biomanufacturing
Developments
John Brown, Integrated Biosystems - Biomanufacturing Operations
Crawford Brown, Eden BioPharm - Novel Expression Systems and
Process Development
Dr. Anthony Lucas, Biovectra dcl - Technology Innovations
Dr. Linda B. Hakes, Schwarz BioSciences - Product Formulation and
Delivery
David Thatcher, Cobra Therapeutics and Sharon Redmond, Celltech -
Moving Products from Research through Development and into
Manufacturing
Dr. Stephen C. Taylor, Chair of BioIndustry Association - Regional
Biomanufacturing Initiatives
Sponsors:
Host - Bavarian Ministry for Economic Affairs
Diamond - Charter Medical Ltd and Roche Diagnostics GmbH
Gold - Serologicals Corporation
Silver - Accentus, BioInvent Production AB, BioProtein
Technologies, BioReliance Limited, Covance, Disynyth RTOP, Inc.,
Excell Biotech, Greenovation Biotech GmbH, Integrated Systems, JRH
Biosciences, Millipore Corporation, Pall Life Sciences, Perbio
Science, Q One Biotech, Scottish Enterprise Edinburgh & Lothian,
Spectrum Europe BV, Stedim and Genetic Engineering News.
Organizers: Bioconferences International, Inc.
(www.bioconferences.com) 800-5-BIOCON
Details: For complete program and registration, visit the web site
http://www.bioconferences.com/ebs.
Limited press attendance. For press credentials please call or
e-mail:
BioConferences International, Inc.
Harriet I. Matysko, Senior Vice President
914-834-3100, ext. 608
Hmatysko@Liebertpub.com.
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion